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Self-regulation of brain activity in humans based on real-time feedback of functional magnetic resonance imaging (fMRI) signal is
emerging as a potentially powerful, new technique. Here, we assessed whether patients with Parkinson’s disease (PD) are able to alter
local brain activity to improve motor function. Five patients learned to increase activity in the supplementary motor complex over two
fMRI sessionsusingmotor imagery. Theyattainedasmuchactivation in this target brain regionasduringa localizerprocedurewithovert
movements. Concomitantly, they showed an improvement inmotor speed (finger tapping) and clinical ratings ofmotor symptoms (37%
improvement of themotor scale of the Unified Parkinson’s Disease Rating Scale). Activation during neurofeedback was also observed in
other cortical motor areas and the basal ganglia, including the subthalamic nucleus and globus pallidus, which are connected to the
supplementary motor area (SMA) and crucial nodes in the pathophysiology of PD. A PD control group of five patients, matched for
clinical severity and medication, underwent the same procedure but did not receive feedback about their SMA activity. This group
attained no control of SMA activation and showed nomotor improvement. These findings demonstrate that self-modulation of cortico-
subcortical motor circuits can be achieved by PD patients through neurofeedback and may result in clinical benefits that are not
attainable by motor imagery alone.
Introduction
Neurofeedback training with real-time brain activation data
obtained by functional magnetic resonance imaging (fMRI) is
emerging as an effective way to self-regulate neural circuits in
the human brain (Weiskopf et al., 2003; deCharms et al., 2004;
deCharms, 2008). This method relies on rapid decoding of
brain states from fMRI data to provide participants with feed-
back, on a moment-to-moment basis, about activity within
predetermined brain regions. Thus, it has the potential to be useful
in upregulating or downregulating neural activity in disease states.
Self-regulation of emotion networks through fMRI-based neuro-
feedback (Caria et al., 2010; Johnston et al., 2011) has been used in
schizophrenia (Ruiz et al., 2011), and fMRI has also been used to
document effects of neurofeedback with electroencephalography
(EEG) in attention deficit/hyperactivity disorder (Beauregard and
Le´vesque, 2006).
However, apart from a study on chronic pain (deCharms et
al., 2005) and a preliminary report on tinnitus (Haller et al.,
2010), the clinical potential of fMRI neurofeedback for neurolog-
ical disorders has not been explored.
Parkinson’s disease (PD) is a particularly suitable target for
such a neurofeedback intervention because imbalance between
cortical and subcortical motor circuits is at the heart of patho-
physiological models (Albin et al., 1989; DeLong, 1990; Obeso et
al., 2008). We chose the supplementary motor area (SMA) as
target area for upregulation because it has direct connections
with the basal ganglia pathways implicated in PD (Mink, 1996;
Nambu et al., 1996) and can also show consistently reduced ac-
tivity in PD patients during the performance of motor tasks
(Playford et al., 1992; Jahanshahi et al., 1995; Haslinger et al.,
2001; Nachev et al., 2008; Munzert et al., 2009). This study was
intended as a proof of principle for the use of fMRI neurofeed-
back for patients with a neurodegenerative disorder. We further-
more wanted to assess whether there might be clinical benefits in
patients with early-stage PDwhen adjunctive treatments are par-
ticularly important to help reduce the amount of dopaminergic
medication, which can have important short- and long-term side
effects.
It has been shown that healthy participants can learn self-
control of motor areas through fMRI neurofeedback (deCharms
et al., 2004). We hypothesized that PD patients without signifi-
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cant cognitive impairment would be able to learn upregulation of
SMA activity. Furthermore, we expected that this upregulation
would be reflected in altered activity patterns in the basal ganglia.
A final prediction was that successful upregulation of the SMA
and practice of the associated strategies would lead to improve-
ments in motor function that would not be seen in a control
group engaged inmotor imagery without specific feedback about
local brain activity.
Materials andMethods
Participants
Ten patients (six males; four females) with PD, aged 39–75 years and in
an early stage of the disease (Hoehn andYahr stage I–III), took part in the
experiment. Our criteria for inclusion in the study was based on the
Hoehn and Yahr stage, but we did not restrict the age range, apart from
anupper age limit of 75 years. All were currently receiving treatmentwith
L-DOPA or dopamine agonists and there was no change in medication
regimen and dosage during the course of the study (except one patient
who was not on any medication) (Table 1). There was no significant
difference in L-DOPA equivalent dosage between the two groups of pa-
tients (t(8)  0.152; p  0.05). They had no history of psychiatric or
other neurological problems and no family history of PD, except for one
patient in the experimental group (early-onset PD) whose mother had
been diagnosed with late-onset PD. The experiment was approved by the
ethics committees of the School of Psychology, Bangor University, and
the local National Health Service Trust, and all patients gave informed
consent.
Procedure
Of the 10 participants, 5 were in the experimental group (EG) (with
feedback) and the other 5 were in the control group (CG) (without
feedback). In the first session, all participants underwent an initial clini-
cal and behavioral assessment, followed by a scan session and postscan-
ning behavioral tests. The second session (2–6 months later, depending
on participant availability) consisted of prescanning and postscanning
behavioral tests and another scan session with neurofeedback/imagery.
The final session (2 weeks after the second scanning session) only con-
sisted of the behavioral test and the final clinical assessment. The study
protocol is summarized in Table 2.
Each scan session started with a localizer run in which patients alter-
nated between 20 s periods of left-handmovement and rest over 10 cycles
to yield reliable estimates of the localization of higher motor areas, in-
cluding the SMA. The localizer run was followed by two runs in which,
instead of moving their hand, the participants had to increase activity in
the target area, the SMA, through motor imagery alone.
Localizer run
In EG and CG, the participants were presented with an image of a ther-
mometer (which had 10 levels) in the center of a colored background at a
visual angle of 4.76°. The image was backprojected onto a projector
screen situated at the end of the bore of the magnet; the participant
viewed the screen via a mirror mounted on the head coil, in front of the
participant’s eyes. When the background was green, their task was to
continually squeeze and release the fingers of their left hand (for 20 s)
until the background was yellow, at which point they had to rest (for
20 s). The thermometer, in the center of the screen, remained blue (i.e.,
no feedback) and did not change throughout the run. They performed 10
cycles of each move and rest (Fig. 1). The run lasted for6.5 min. This
simple motor task has been shown to reliably activate motor networks,
including the SMA that we aimed to target (Gerloff et al., 1997).
Neurofeedback/imagery runs
EG. During the two neurofeedback runs (6.5 min each), the procedure
was similar to the localizer run, but here, instead of moving their hand,
the participants had to increase activity in the target area via motor
imagery. They received continuous feedback about the height of activa-
tion through the thermometer display, where the number of red bars
increased with increasing fMRI signal (Fig. 1). We informed them that
this area was involved inmotor control and thatmotor imagerymight be
an effective way of increasing its activity but did not prescribe any strat-
egy. Participants were therefore free to think of any type of movement.
CG. The procedure for the control group was similar to that of the
experimental group, the difference being that they did not receive any
feedback about activation in the target area during the imagery runs.
They were asked to look at the thermometer display (which showed
activation taken from a subject in the experimental group) but to ignore
the changes that took place. Their instructions were to try and increase
activity in the motor area of the brain by using motor imagery without
actual movement. At debriefing sessions after the scanning, participants
Table 1. Demographic, clinical measures andmedication of PD patients
Patient Sex Age Duration of illness Hoen and Yahr stage Total L-DOPA Dopamine agonists: Pram (mg of salt); Rop (mg) MAOB inhibitors: rasagiline (mg)
LEDD to the nearest mg
(LeWitt et al., 2007)
1 F 60 4 years 1 100 (50) Pram 4.5 (1.5) 1 550
2 F 39 1 year 1 Rop 20 1 400
3 M 63 3 years 1 Rop 18 1 350
4 M 75 3 years 1 150 (50) 1 150
5 M 52 4 years 1 Pram 4.5 (1.5) 1 450
6 M 75 1 year 1 — — —
7 F 64 4 years 1 500 — — 500
8 M 67 3 years 1 300 (100) — — 300
9 M 71 4 years 2 300 (100) Pram 3 (1) — 600
10 F 71 11 years 3 300 (100) Pram 3 (1) — 600
Patients 1–5 belong to the experimental group, and patients 6–10 belong to the control group. Abbreviations: Pram, Pramipexole; Rop, ropinirole; MAOB, monoamine oxidase E inhibitor; LEDD, L-DOPA equivalent daily dosage.
Table 2. Study protocol
Session Prescan Scan Postscan
1 UPDRS T1 anatomical POMS
VMIQ-2 Localizer run Stroop test
POMS Neurofeedback run 1 GoNoGo task
Stroop test Neurofeedback run 2 Finger tapping
GoNoGo Task
Finger-tapping test
2–6 months: Practice of neurofeedback strategy at home (EG)
2 months: Practice of motor imagery at home (CG)
2 VMIQ-2 Localizer run POMS
POMS Neurofeedback run 1 Stroop test
Stroop test Neurofeedback run 2 GoNoGo task
GoNoGo task Finger tapping
Finger-tapping test
2 weeks: Practice of neurofeedback strategy/motor imagery at home
3 UPDRS No scan
POMS
Stroop test
GoNoGo task
Finger-tapping test
The study included assessments at three time points with fMRI scanning on the first two sessions, and intervening
practice periods. See Materials and Methods. Abbreviations: POMS, Profile of Mood States; VMIQ-2, Vividness of
Movement Imagery Questionnaire 2.
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in both groups reported using complex imagery of complex motor tasks,
including their favorite sports or manual tasks from their work.
In the time between the two scan sessions, participants in the EG were
asked to practice the strategy they had found to be effective during the
neurofeedback sessions in the laboratory at home on a daily basis, while
the CG participants were also asked to practice the motor imagery they
used in the scanner. Importantly, however, they were instructed to re-
frain from overt motor practice. Participants did not keep a record of
how long they practiced motor imagery every day, but reported doing so
on a regular basis. They also reported having no side effects from taking
part in the experiment. All assessments were conducted during the “on”
medication phase,2–3 h after the last dose of medication (for medica-
tion details, see Table 1).
fMRI: data acquisition
Functional and anatomical scans were performed on all participants in a
3 Tesla Philips Achieva (Philips Healthcare)MRI scanner at theWolfson
Centre for Cognitive Neuroscience, Bangor University. A high-resolution
T1-weighted anatomical scan (176 slices) covering the whole brain was
acquired during the first scan session using a turbo field echo gradient
echo pulse sequence. Functional data was obtained using a single-shot
EPI sequence (TR, 2 s; TE, 30 ms; 30 slices; 3 mm thick; flip angle, 90°;
in-plane resolution, 2 2mm). The first four volumes were discarded to
allow for T1 equilibration effects. A total of 204 volumeswere acquired in
each functional run for each participant.
Electromyography
We used MRI-compatible surface electromyography (EMG) to measure
muscle activity (tremors) during the first scan session. Data were col-
lected using an MR Plus amplifier and MRI-compatible electrodes and
recorded on a Dell laptop using the Vision Recorder software (Brain
Products). A sampling rate of 5000 Hz was used. The participants were
fitted with two electrodes on the abductor pollicis brevis muscle of their
affected hand (left side for all participants) along with a reference elec-
trode at the base of thewrist and a ground electrode near the elbowbefore
they went into the scanner.
fMRI data analysis (on-line)
Data from the localizer and neurofeedback runs were analyzed on-line.
fMRI data were transferred as they were acquired from the reconstructor
to an analysis computer through the Philips Direct Reconstructor Inter-
face (DRIN) interface, which has been used in previous neurofeedback
studies (Johnston et al., 2010). The data are read volume by volume by
the real-time fMRI software package, Turbo-BrainVoyager (TBV) (Brain
Innovation). The first four volumes were discarded to avoid T1 satura-
tion effects. The data are corrected for angular and translational motion
in the Cartesian coordinate system and analyzed with an incremental
general linear model. For the localizer run, we used one predictor for
the movement blocks (convolved with a canonical hemodynamic re-
sponse function) to identify areas of movement-related activation.
The t value for the contrast between movement and rest in the local-
izer map was set at 3.
We took the peak midline activation from the posterior part of the
mesial aspect of the superior frontal gyrus within 2 cm of the paracentral
sulcus during the localizer run as the target area for the neurofeedback
runs. The region of interest was selected by choosing the whole of the
extent in the x–y plane (on the axial slice) encompassing the activity in
the SMA with an extent across three slices in the z direction.
In the neurofeedback runs, the “thermometer” displayed to partici-
pants (Fig. 1) the percentage signal change from baseline from the top
third ofmost active voxels of the region of interest for an average of three
time points. The baseline value was set to the average signal intensity
value recorded from the last three time points during the preceding
“fixation” period to the current upregulation block. There is a time lag
and participants are informed of this. The thermometer display was con-
tinuously updated every 2 s with the third most active voxels. The stim-
ulation interface was custom programmed in PsychoPy (Peirce, 2007,
2008) and presented from a Macintosh computer. This interface allows
updating of feedback within1 s of data acquisition.
fMRI data analysis (off-line)
Once the scan sessionwas completed, the datawere further preprocessed,
off-line, using the Brain Voyager software package (version 2.1). Motion
correction and temporal filtering were performed on the raw data to
remove artifacts due to head movement and physiological noise. The
functional data were coregistered to the T1 anatomical scan obtained.
Finally, the data were transformed into Talairach space, spatially
smoothedwith aGaussian filter FWHMof 6mm, and temporally filtered
(Gaussian FWHM, 3 s). We defined a general linear model (GLM) of the
localizer experiment with one predictor for the “move” condition. For
the neurofeedback runs, a single predictor for “upregulation” was used.
In both cases, the regressors were convolved with a canonical hemody-
namic reference function to account for the temporal delay and disper-
sion of the hemodynamic response. In both cases, we added the six
motion confounds for each run to the GLM.
We used these models both for a group whole-brain analysis and for a
ROI analysis. For the latter, we computed aGLMover the neurofeedback
runs across the individually localized target areas. The aim of this proce-
dure was to ascertain the significance of activation changes in the target
area during neurofeedback. The groupwhole-brain analysis was aimed at
investigating which other brain regions, in addition to the target area,
were activated during the localizer and neurofeedback tasks. We com-
puted a GLM for the 19 neurofeedback runs from the experimental
group (four for four participants; three for one participant, due to scan-
ner problems during his fourth session) and 20 neurofeedback runs from
the control group separately and analyzed the effects of upregulation
versus rest. We applied a threshold of p  0.001 (fixed-effects analysis,
Bonferroni corrected). Because of the low number of participants, we
could not perform a random-effects analysis, and thus the validity of our
results is confined to the sample detailed here. For areas with the highest
activation during neurofeedback, we also compared activation levels
(GLM  values) between neurofeedback and localizer runs with theWil-
coxon signed-rank test.
EMG analysis
During analysis, the data were downsampled to 1000 Hz. A 20 Hz low-
pass filter (48 db/oct) and 1 Hz high-pass filter (12 db/oct) were applied
to reduce scanner artifacts.
Each period of data corresponding to “movement”/“imagined move-
ment” and “rest” was segmented into 4 s epochs. Fast Fourier transfor-
mation on the segmented data was performed using Vision Analyzer 2
Figure1. Experimental procedure. During fMRI scanning, participants sawa yellowor green
screen with a central thermometer. During the localizer runs, patients were required to rest
when a yellow background appeared (for 20 s) and squeeze their left hand when the back-
ground turned green (for 20 s). The thermometer display remained blue throughout the run. A
run consisted of 10 cycles. The two neurofeedback runs were similar to the localizer run except
here the patients had to increase brain activity when the background turned green without
overt movement. As brain activity in the target area increased, the blue bars on the thermom-
eter filled up with red, and as activity decreased, the red bars empty back to blue.
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software. This generated a profile for the movement and rest conditions
using the localizer, which was comparable with the imagined movement
and rest conditions.
Clinical and behavioral assessments and analysis
Unified Parkinson’s Disease Rating Scale.TheUnified Parkinson’sDisease
Rating Scale (UPDRS) is a rating scale used to quantify the signs and
symptoms of PD and ismade up of different sections focusing on varying
aspects of the impact of the disease on daily function: (1) mentation,
behavior, and mood; (2) activities of daily living (the modified Schwab
and England activities of daily living scale); and (3) motor examination.
The scale is administered in the form of an interview and each subsection
is given a score of 0–4. Higher scores denote higher impairment. In the
present study, we only used the motor part of the scale because the
procedure primarily targeted motor circuits. It was administered by co-
author J. V. Hindle, a consultant physician specializing in PD, at the
beginning of the first and after the third session to yield estimates of
changes in motor functions.
Finger-tapping test. We used a standardized finger-tapping device. A
wooden board with an electronic counter attached to it (to count the
number of taps) on which the participants had to place their hand with
the palm resting flat on the board and the index finger placed on a
movablemetal piece attached to the counter. The tapwas valid only if the
index finger reached a certain height before touching the surface of the
board.Motor speedwasmeasured as number of taps perminute for both
hands. Each participant completed three 20 s trials, four 15 s trials, or six
10 s trials, although this was dependent on how soon participants expe-
rienced fatigue. These interval times were maintained for each partici-
pant across all sessions. The participants performed this test before and
after both scan sessions and at the final assessment, after they had had
time to familiarize themselves with the device.
We only report the UPDRS and finger tapping as these are our main
outcome measures and since the main target is the motor circuits.
Statistical analysis
The behavioral and clinical measures from the first and the last session
for the participants were compared by using the Wilcoxon signed-rank
test (one-tailed) in SPSS (version 15; SPSS). This was done for both the
experimental and control groups.
UPDRS.We compared the total scores from the motor exam of the
UPDRS from session 1 and session 3 for each of the two groups
separately.
Figure2. The region-of-interest analysis shows the success of the neurofeedback procedure for the experimental group.A, Example of target area for the neurofeedback run for one patient (x
6). B–D, The mean time course during the localizer run (B), neurofeedback run 1 (C), and neurofeedback run 2 (D). The pink bars in B–D indicate activity in the target area during periods of
upregulation, and the gray bars indicate rest periods. The patient was able to increase activity during upregulation and decrease activity during the rest periods for both neurofeedback runs. x-axis,
Time (1TR 2 s); y-axis, fMRI signal strength. E, Mean values for the localizer runs and neurofeedback/imagery runs during both the scan sessions for all patients in the experimental and control
group shown as scatter plots depicting the values for each individual person. The plots indicate that all patients in the experimental group were able to activate the target area during the
neurofeedback (NF) session; this was not the case for all CG patients. Note: One patient in the EG did not show significant localizer (LOC) activation in scan 2, but this area was used to define the ROI
for the neurofeedback runs based on the anatomical criteria, and then successfully upregulated.
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Finger-tapping test.The total number of finger taps perminute for each
hand was calculated for each participant and a comparison between ses-
sion 1 and session 3 was made to see whether there was a significant
increase in the number of finger taps attained as a result of the neuro-
feedback for both groups separately.
Results
For the EG functional activation maps for the localizer task,
thresholded at p  0.001 (Bonferroni corrected), revealed a sig-
nificantly activated cluster in the SMA for each participant. The
target area used for neurofeedback was centered on the peak
voxel of activation in the SMA, and we averaged the signal from
all suprathreshold voxels in a 10  10  10 mm3 cubic region
(Fig. 2A–D for example from one patient). We calculated the
activation difference between upregulation and rest in the target
area during neurofeedback runs at the group level with a one-
sample t test on the  values. The changes were significant for the
EG during both neurofeedback runs in session 1 (run 1: t(4) 
7.33, p  0.002, two-tailed; run 2: t(4)  6.45, p  0.003, two-
tailed) and session 2 (run 1: t(4) 5.64, p 0.005, two-tailed; run
2: t(3) 4.705, p 0.018, two-tailed).
Activity in the SMA target area during the neurofeedback runs
for the EG was similar to the activity during actual movement in
the localizer runs (p 0.05, Wilcoxon’s signed-rank test). Thus,
the analysis of activity in the target area showed that all partici-
pants were able to activate the SMA during the upregulation
blocks without changes in overt movements, which was mea-
sured specifically for the abductor pollicis brevis muscle of the
hand used for the localizer, by the EMG analysis (Fig. 3).
For the CG, we identified an area in the SMA with similar
criteria to the target area of the EG. Activity of this area in the
localizer blocks was not significantly different from the EG local-
izer blocks: t(18) 1.158, p 0.262. However, activity in this area
during the imagery runs was lower than during the localizer
blocks in the CG and this decrease was statistically significant in
Figure3. EMG recordings ruledout the effect of overtmovements. EMGdata (for onepatient) from two channels during the localizer andneurofeedback runs over a similar timeperiod. Theupper
pair of traces shows the expected increased innervation of hand muscles during the movement periods. No such activity was observed during the corresponding (upregulation) periods of the
neurofeedback run (bottompair of traces). The right columnshows that the frequency signatureof theEMGwas similar duringneurofeedback (NF) to that recordedduring rest andverydifferent from
that recorded during overt movements.
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both scan sessions (session 1: run 1, p 
0.043; run 2, p  0.043; session 2: run 1,
p  0.043; run 2, p  0.043, Wilcoxon’s
signed-rank test). Indeed, activation in
the imagery runs did not differ significantly
frombaseline (session 1: run 1, t(4) 0.924,
p  0.408; run 2, t(4)  1.296, p  0.265;
session 2: run 1, t(4) 1.127, p 0.323; run
2, t(4)0.389,p0.717). This difference in
groupeffects—only theEGattainedcontrol
over SMA activity—suggests that neuro-
feedback was helpful in learning to upregu-
late the target area.
Whole-brain maps for the upregula-
tion predictor for the EG showed bilateral
activation in the SMA, precentral gyrus
(PCG), subthalamic nucleus (STN), thal-
amus, globus pallidus internus (GPi), the
insula, and the cerebellar vermis (Fig. 4A,
Table 3). We found areas of deactivation
in the posterior cingulate and the anterior
medial frontal cortex. All the activated ar-
eas described above were significantly less
active (p  0.05) during the neurofeed-
back runs compared with the preceding
localizer (Fig. 4B) except for the insula.
However, the individually identified tar-
get areas showed equal activation during
the neurofeedback run (as already shown
by the ROI analysis; Fig. 2E). The whole-
brain contrast map for localizer versus
neurofeedback (p  0.001, corrected) confirmed this pattern of
overall higher activation for the localizer runs.
The CG showed bilateral activation in the SMA, PCG, and the
insula and GP but no activation in the STN during the upregula-
tion blocks. We also found areas of deactivation in the cingulate
gyrus, middle temporal gyrus, and parietal areas in the CG. To
extract whole-brain effects that were specific for the EG, we also
contrasted the upregulation maps from the EG and CG and
found higher activation in the EG comparedwith theCG in SMA,
PCG, STN, and cerebellum (Fig. 4B, Table 4).
There was no baseline difference between the scores on the
UPDRS, a standard global measure of PD state of the EG and CG
(t(8)0.263; p 0.799), but only the EG showed clinical and
functional improvements. On the UPDRS, the EG had a 37%
improvement of motor functions from session 1 (mean score,
14.2) to session 3 (mean score, 9) (p 0.042,Wilcoxon’s signed-
rank test). No such effect was seen in the CG (mean scores: ses-
sion 1, 15; session 3, 13.4; p 0.336). Lower scores denote better
motor function. Patients in the EG group improved across the
five symptom clusters defined byHagell and Brundin (2009) (ax-
ial/postural/gait, rest tremor, postural tremor, rigidity, limb bra-
dykinesia), but no patient showed improvement on all five. The
cluster with the most consistent improvement (four of five pa-
tients) was limb bradykinesia. A comparison of the number of
finger taps attained in session 1 (before scan, mean number of
taps, 210.6) with that in session 3 (mean number of taps, 266.2)
(Fig. 5) for the affected hand showed that participants in the
experimental group improved significantly over time (p 
0.043), whereas the control group did not (session 1, before scan,
meannumber of taps, 177; session 3,meannumber of taps, 178.2;
p 0.686).
Discussion
Neurofeedback is an attractive tool for any disorder in which
imbalance between neural circuits is suspected. In the present
proof-of-principle study, patients who received neurofeedback
successfully upregulated a higher cortical motor area and con-
comitantly influenced activity in basal ganglia circuits implicated
in PD. This training resulted in significant and clinically relevant
improvement of motor functions. Neurofeedback in PD might
work in analogy to physical stimulation techniques, such as trans-
cranial magnetic or direct current stimulation, but with the ad-
vantage of being less invasive. Assuming that patients can learn to
transfer the strategies used during neurofeedback into real-life
settings, it might also become possible to sustain the clinical ben-
efits without regular stimulation sessions.We chose fMRI- rather
than EEG-based neurofeedback because fMRI has the potential
advantage of allowing participants specifically to target subcom-
ponents of the motor network. Furthermore, with whole-brain
coverage, it is possible to detect the effects of successful self-
regulation of the SMA in other parts of the brain, including sub-
cortical networks, and thus to identify potential compensatory
circuits in PD.
Our patients achieved fast and consistent upregulation of a
higher motor area, the SMA. Successful upregulation of the SMA
during neurofeedback constitutes a notable difference to mere
mental imagery paradigms, in which activation in higher motor
areas was consistently lower than during motor execution
(Pascual-Leone et al., 1995). Yet SMA activity during motor im-
agery is detectable at single subject level, even in neurological
patients (Monti et al., 2010). It may therefore seem puzzling that
our CG produced no significant SMA activation increase over
baseline in the imagery blocks. However, the scatter plots show
Figure 4. A, Whole-brain analysis revealed themodulation of cortico-subcortical circuits through neurofeedback.Whole-brain
analysis for the neurofeedback runs shows activation in the SMA, PCG, GP ( y3/z 7), and a contiguous cluster covering STN
and cerebellum (CB). For detailed coordinates, see Table 3.B, Plot showing values of brain areas (whole-brain analysis for EG) for
theneurofeedback (NF) and localizer (LOC) runs. All areaswere found tobemore active during the localizer runs comparedwith the
neurofeedback runs. C, Contrast map of the two groups during the NF runs. A and C show coronal and axial views in radiological
convention. For detailed coordinates, see Table 4 ( y 0; z4).
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that the deficit in the CGwasmainly produced by higher variabil-
ity across runs and patients than in the EG. Neurofeedback may
thus aid more consistent activation of higher motor areas during
imagery, especially in PD. Previous studies of motor imagery in
PD have reported both altered (Thobois et al., 2000) and normal
(Cunnington et al., 2001) recruitment of the SMA. These studies
used predefined or cued imagery, whereas the motor imagery
used in the present studywas self-initiated, whichwas likelymore
difficult for patients. Indeed, a recent study shows that PD pa-
tients benefit from external cues in obtaining more vivid motor
imagery (Heremans et al., 2011). They may therefore have ac-
quired additional guidance or support from neurofeedback to
obtain reliable SMA activation.
The results presented here show that PD patients can increase
activity in the SMA by motor imagery with the help of real-time
neurofeedback training. The neurofeedback session and the prac-
tice of the successful upregulation strategy at home resulted in
improvements in motor function. Effects were seen over a 2
month interval and were at least as strong as those obtained with
noninvasive stimulation [37% improvement in UPDRS-III com-
pared with 20% in the study by Hamada et al. (2008)], although
our study was too small to allow for formal quantitative compar-
isons of treatment effects.
Modulation of cortical areas with transcranial magnetic
(Lefaucheur, 2006) or direct current stimulation (Fregni et al.,
2006), which has been proposed as an alternative, or adjunct, to
invasive stimulation, and direct epidural stimulation have re-
cently been piloted as well (Lefaucheur, 2009). Here, too, one of
the key target areas has been the SMA (Fregni et al., 2006; Lefau-
cheur, 2006, 2009; Hamada et al., 2008, 2009). The clinical effects
of stimulation of primary and higher motor areas, especially on
motor functions, have been promising, although short-lived and
strongly dependent on stimulation parameters. The ability and
willingness of patients to practice the neurofeedback strategy at
homemay be important for long-lasting symptom improvement,
which has so far been one of the weaknesses of the external
stimulationmethods. In any clinical application, neurofeedback
would not be intended as an alternative to medication but as an
add-on therapy, possibly allowing saving on the dose of dopami-
nergic medication. The practicability of the current procedure is
supported by the patients’ positive subjective responses and high
compliance. However, further studies, following the framework
for the evaluation of complex interventions (Craig et al., 2008)
are needed to address its efficacy and cost effectiveness.
What then are the potential mechanisms for motor improve-
ment afforded by neurofeedback? In PD, compensatory mecha-
nisms in the cortico-basal-ganglia-thalamocortical network may
sustain neurological functions in the face of the progressive loss
of dopaminergic input (Park and Reuter-Lorenz, 2009), slowing
down the progression of the clinical symptoms of the disorder.
This compensation may be enabled by neural degeneracy,
whereby normally redundant neural pathways become function-
ally relevant when the original pathways cease to function (Edel-
man andGally, 2001). Through the upregulation of the SMA and
the associated network of thalamic/subthalamic areas and GPi,
patients may have increased the compensatory activity of such a
pathway. The SMA controls the programming of complexmove-
ments (Roland et al., 1980; Stephan et al., 1995), and its training
may thus be particularly beneficial for patients with difficulties
initiating movements (hypokinesia) or motor slowing (bradyki-
nesia), as observed in the present study. The SMA sends direct
signals to the subthalamic nucleus through a hyperdirect pathway
(Nambu et al., 1996). It has also been shown that deep brain
stimulation of the subthalamic nucleus increases GPi activity and
improves symptoms (Hashimoto et al., 2003; Montgomery and
Gale, 2008; Vitek, 2008). Therefore, increased activation of the
SMAwould lead to an increase in direct input to the subthalamic
nucleus, in turn leading to increased GPi activity, causing a
change in the pattern of neural activity within the basal ganglia
circuit or increasing the regularity of GPi neurons potentially
resulting in an improvement of symptoms. Thismodel is in keep-
ing with recent results from a motor learning study in healthy
individuals, where the functional coupling between SMA and
Table 3. Areas of the brain activated and deactivated during neurofeedback
Peak x/y/z t value p value
Cluster size
(mm3)
Brain areas activated
Supplementary motor area/medial
frontal gyrus
1/5/55 18.971279 0.000000 10,711
Left precentral gyrus 36/15/48 12.780833 0.000000 24,791
Right precentral gyrus 29/17/51 12.950804 0.000000 11,800
Left STN region 13/14/3 11.916059 0.000000 1680
Right STN region 17/14/2 9.442472 0.000000 1006
Left globus pallidus 19/0/9 9.907552 0.000000 734
Right globus pallidus 17/5/6 10.168879 0.000000 668
Left insula 31/19/9 11.160399 0.000000 10,811
Right insula 32/19/3 12.689801 0.000000 5824
Brain areas deactivated
Posterior cingulate 2/50/27 14.176578 0.000000 1666
Anterior medial frontal cortex 4/46/34 13.245537 0.000000 10,233
This table summarizes the activated and deactivated areas for the contrast between the upregulation predictor and
baseline in the EG.
Table 4. Group activation differences
Brain areas Peak x/y/z t value p value Cluster size (mm3)
Supplementary motor area 1/5/54 8.791275 0.000000 676
Right precentral gyrus 41/11/48 10.25540 0.000000 691
Right STN 5/20/6 10.92679 0.000000 318
Insula 32/16/3 8.540370 0.000000 22
Left STN 7/20/3 8.799783 0.000000 92
Left precentral gyrus 49/2/30 13.15048 0.000000 3639
This table summarizes the areas showing significantly different activation between the upregulation blocks of the
EG and the imagery blocks of the CG.
Figure 5. The functional improvement was apparent from the increase in finger-tapping
frequency.Meannumber of finger taps is shown for all sessions,with error bars showing the SD.
Patients in the experimental groupwere able to increase the number of finger taps from session
1 to session 3 (the final assessment) (p 0.05).
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basal ganglia increased with practice (Ma et al., 2010). However,
with the present design, we cannot single out any particular com-
ponent of the activated network as being responsible for the po-
tential clinical benefits.
We are confident that the clinical effects were not just pro-
duced by the attention the patients received from researchers or
by the time on task because numerous trials have shown that
motor symptoms do not improve in sham conditions of equally
time-consuming trials (Boggio et al., 2006; Fregni et al., 2006;
Lefaucheur, 2009), which was also not the case in our CG, who
received no feedback withmotor imagery and showed no clinical
improvement. However, it is impossible to disentangle the effects
of the direct neurofeedback sessions from those of the mental
training. We would assume that the mental training at home,
which involved the same strategy that was effective for the up-
regulation of SMAduring scanning, delivered regular “boosts” to
the SMA-subcortical network. Thus, the brain-focused approach
to mental training, which was only possible because of the initial
neurofeedback session, sets the present approach apart from tra-
ditional mental imagery training, which has consistently shown
weaker effects than those observed in the present study (Herbert
et al., 1998; Lotze and Halsband, 2006). However, larger trials
with longer observation periods, will be needed for a definitive
assessment of this issue. Participants reported no side effects, and
the safety and tolerability of fMRI neurofeedback has recently
been confirmed in a large study (Hawkinson et al., 2011).
A limitation of the study is the small sample size and reliance
on null effects in imaging and clinical outcomes for the CG. Ab-
sence of a record of the imagery practiced at home, lack of a
blinded UPDRS rating, and the inability to assess motor func-
tions during the off medication state are further limitations that
will have to be addressed in the next stage of the evaluation cycle
(Craig et al., 2008). A comparison of the effects of neurofeedback
on patients with early and late onset of the disease and patients on
different medication regimens might also be of interest.
In conclusion, this new intervention program holds promise
for clinical practice and should now undergo further rigorous
clinical testing. This neurofeedback protocol aims to maximize
use of surviving neurons in the brains of PDpatients and improve
compensatory mechanisms without any known side effects, and,
most importantly, directly involves the patients, giving them a
sense of control over their treatment and eventual improvement
of symptoms. Although it may not stop the progression of the
disease, it has the potential to alter the course ofmotor symptoms
and possibly reduce drug requirements in early disease. This may
have the effect of delaying more severe motor complications and
improve the quality of life of the patients affected by PD.
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